Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
Authors
Keywords
α-synuclein, Iron, Dopamine, Endosomal trafficking, Oxidative stress, Post translational modification, N-terminal acetylation, Phosphorylation, Oxidation
Journal
Molecular Neurodegeneration
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-07
DOI
10.1186/s13024-017-0186-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
- (2017) Fabio A. Zucca et al. PROGRESS IN NEUROBIOLOGY
- Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations
- (2016) Igor Dikiy et al. ACS Chemical Biology
- Lysines, Achilles’ heel in alpha-synuclein conversion to a deadly neuronal endotoxin
- (2016) Nicoletta Plotegher et al. AGEING RESEARCH REVIEWS
- Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease
- (2016) Shounak Baksi et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Impact of N-terminal Acetylation of α-Synuclein on Phospholipid Membrane Binding and Fibril Structure
- (2016) Aditya Iyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
- (2016) Abdel A. Belaidi et al. JOURNAL OF NEUROCHEMISTRY
- Structural disorder of monomeric α-synuclein persists in mammalian cells
- (2016) Francois-Xavier Theillet et al. NATURE
- Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
- (2016) Bruce Do Van et al. NEUROBIOLOGY OF DISEASE
- Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
- (2016) Lucie Hopes et al. PLoS One
- Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites
- (2016) Andres Binolfi et al. Nature Communications
- Dopamine Transporter Activity Is Modulated by α-Synuclein
- (2015) Brittany Butler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, andin Vivo
- (2015) Martial Kamdem Mbefo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brain region-dependent differential expression of alpha-synuclein
- (2015) Katsutoshi Taguchi et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Parkinson's Disease Iron Deposition Caused by Nitric Oxide-Induced Loss of -Amyloid Precursor Protein
- (2015) S. Ayton et al. JOURNAL OF NEUROSCIENCE
- Dopamine midbrain neurons in health and Parkinson’s disease: Emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels
- (2015) E. Dragicevic et al. NEUROSCIENCE
- DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity
- (2015) Patricia Muñoz et al. TOXICOLOGICAL SCIENCES
- Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
- (2015) Ulf Dettmer et al. Nature Communications
- Efficient Modification of Alpha-Synuclein Serine 129 by Protein Kinase CK1 Requires Phosphorylation of Tyrosine 125 as a Priming Event
- (2014) Jonas Kosten et al. ACS Chemical Neuroscience
- The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of -synuclein, and enhances its secretion and nuclear localization in cells
- (2014) M.-B. Fares et al. HUMAN MOLECULAR GENETICS
- In Vitro Phosphorylation Does not Influence the Aggregation Kinetics of WT α-Synuclein in Contrast to Its Phosphorylation Mutants
- (2014) Sarah Schreurs et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The H50Q Mutation Induces a 10-fold Decrease in the Solubility of α-Synuclein
- (2014) Riccardo Porcari et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Divergent effects of the H50Q and G51DSNCAmutations on the aggregation of α-synuclein
- (2014) Nicola J. Rutherford et al. JOURNAL OF NEUROCHEMISTRY
- Protective and toxic roles of dopamine in Parkinson's disease
- (2014) Juan Segura-Aguilar et al. JOURNAL OF NEUROCHEMISTRY
- Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
- (2014) K. J. Vargas et al. JOURNAL OF NEUROSCIENCE
- α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner
- (2014) Guowei Yin et al. NEUROBIOLOGY OF DISEASE
- Diverse Metastable Structures Formed by Small Oligomers of α-Synuclein Probed by Force Spectroscopy
- (2014) Krishna Neupane et al. PLoS One
- Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers
- (2014) Georg Sebastian Nübling et al. PLoS One
- β-Amyloid Precursor Protein Does Not Possess Ferroxidase Activity but Does Stabilize the Cell Surface Ferrous Iron Exporter Ferroportin
- (2014) Bruce X. Wong et al. PLoS One
- An iron–dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta
- (2014) Dominic J. Hare et al. Chemical Science
- Nigral Iron Elevation Is an Invariable Feature of Parkinson’s Disease and Is a Sufficient Cause of Neurodegeneration
- (2014) Scott Ayton et al. Biomed Research International
- Labile iron in cells and body fluids: physiology, pathology, and pharmacology
- (2014) Zvi Ioav Cabantchik Frontiers in Pharmacology
- Structures of the E46K Mutant-Type α-Synuclein Protein and Impact of E46K Mutation on the Structures of the Wild-Type α-Synuclein Protein
- (2013) Olivia Wise-Scira et al. ACS Chemical Neuroscience
- G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome
- (2013) Suzanne Lesage et al. ANNALS OF NEUROLOGY
- Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
- (2013) Laurie H. Sanders et al. FREE RADICAL BIOLOGY AND MEDICINE
- Parkinson disease: from pathology to molecular disease mechanisms
- (2013) David T. Dexter et al. FREE RADICAL BIOLOGY AND MEDICINE
- N-terminal Acetylation Stabilizes N-terminal Helicity in Lipid- and Micelle-bound α-Synuclein and Increases Its Affinity for Physiological Membranes
- (2013) Igor Dikiy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Site-Specific Interaction between α-Synuclein and Membranes Probed by NMR-Observed Methionine Oxidation Rates
- (2013) Alexander S. Maltsev et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K
- (2013) Luisel R. Lemkau et al. PLoS One
- Is R2* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up
- (2013) Miguel Ulla et al. PLoS One
- Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
- (2012) Scott Ayton et al. ANNALS OF NEUROLOGY
- α-Synuclein knockout mice have cognitive impairments
- (2012) V.S. Kokhan et al. BEHAVIOURAL BRAIN RESEARCH
- Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties
- (2012) Alexander S. Maltsev et al. BIOCHEMISTRY
- Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context
- (2012) Vicente Sancenon et al. HUMAN MOLECULAR GENETICS
- α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, andEscherichia coliExists Predominantly as Disordered Monomer
- (2012) Bruno Fauvet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease
- (2012) David S. Goldstein et al. JOURNAL OF NEUROCHEMISTRY
- Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
- (2012) M. J. Diogenes et al. JOURNAL OF NEUROSCIENCE
- Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
- (2012) Peng Lei et al. NATURE MEDICINE
- Single-Channel Electrophysiology Reveals a Distinct and Uniform Pore Complex Formed by α-Synuclein Oligomers in Lipid Membranes
- (2012) Felix Schmidt et al. PLoS One
- Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene
- (2012) N. Jahanshad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impaired neurotransmission caused by overexpression of -synuclein in nigral dopamine neurons
- (2012) M. Lundblad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic Analysis of Lysine Acetylation Sites in Rat Tissues Reveals Organ Specificity and Subcellular Patterns
- (2012) Alicia Lundby et al. Cell Reports
- Phosphorylation of α-Synuclein at Y125 and S129 Alters Its Metal Binding Properties: Implications for Understanding the Role of α-Synuclein in the Pathogenesis of Parkinson’s Disease and Related Disorders
- (2011) Yu Lu et al. ACS Chemical Neuroscience
- CSPα knockout causes neurodegeneration by impairing SNAP-25 function
- (2011) Manu Sharma et al. EMBO JOURNAL
- Synuclein modulation of monoamine transporters
- (2011) Adam W. Oaks et al. FEBS LETTERS
- Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes
- (2011) Naomi P. Visanji et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen
- (2011) Jack T. Rogers et al. JOURNAL OF NEURAL TRANSMISSION
- Iron Efflux from Oligodendrocytes Is Differentially Regulated in Gray and White Matter
- (2011) K. Schulz et al. JOURNAL OF NEUROSCIENCE
- Ceruloplasmin Oxidation, a Feature of Parkinson's Disease CSF, Inhibits Ferroxidase Activity and Promotes Cellular Iron Retention
- (2011) S. Olivieri et al. JOURNAL OF NEUROSCIENCE
- In vivo demonstration that -synuclein oligomers are toxic
- (2011) B. Winner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
- (2010) Dalton James Surmeier et al. ANTIOXIDANTS & REDOX SIGNALING
- The N-Terminus of the Intrinsically Disordered Protein α-Synuclein Triggers Membrane Binding and Helix Folding
- (2010) Tim Bartels et al. BIOPHYSICAL JOURNAL
- Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease
- (2010) James A. Duce et al. CELL
- The relevance of iron in the pathogenesis of Parkinson’s disease
- (2010) Jeswinder Sian-Hülsmann et al. JOURNAL OF NEUROCHEMISTRY
- Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits -Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions
- (2010) K. E. Paleologou et al. JOURNAL OF NEUROSCIENCE
- Exploring the Structural Details of Cu(I) Binding to α-Synuclein by NMR Spectroscopy
- (2010) Andres Binolfi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
- (2010) Venu M. Nemani et al. NEURON
- Iron Deficiency Anemia and Cognitive Function in Infancy
- (2010) R. C. Carter et al. PEDIATRICS
- -Synuclein triple knockout mice reveal age-dependent neuronal dysfunction
- (2010) B. Greten-Harrison et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- -Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
- (2010) J. Burre et al. SCIENCE
- Phosphorylation of α-synuclein upregulates tyrosine hydroxylase activity in MN9D cells
- (2009) Bo Wu et al. ACTA HISTOCHEMICA
- Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation
- (2009) Su Ling Leong et al. FREE RADICAL BIOLOGY AND MEDICINE
- Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease
- (2009) Ning Song et al. FREE RADICAL BIOLOGY AND MEDICINE
- α-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells
- (2009) Christine L. Kragh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tonicity-dependent induction of Sgk1 expression has a potential role in dehydration-induced natriuresis in rodents
- (2009) Songcang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Binding of α-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes
- (2009) Yong Peng et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of α-Synuclein in a pH-Dependent Manner
- (2009) Chi L.L. Pham et al. JOURNAL OF MOLECULAR BIOLOGY
- Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson’s disease pathogenesis
- (2009) Kai-Yin Chau et al. JOURNAL OF NEUROCHEMISTRY
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
- (2009) Eugene V. Mosharov et al. NEURON
- Iron, the substantia nigra and related neurological disorders
- (2008) Amanda M. Snyder et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Parkinson's disease: The syndrome, the pathogenesis and pathophysiology
- (2008) Anna L. Bartels et al. CORTEX
- Oligodendrocytes and myelination: The role of iron
- (2008) Bozho Todorich et al. GLIA
- Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein
- (2008) Katerina E. Paleologou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of α-Synuclein
- (2008) Elisa A. Waxman et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The phosphorylation state of Ser-129 in human -synuclein determines neurodegeneration in a rat model of Parkinson disease
- (2008) O. S. Gorbatyuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
- (2008) J. Salazar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started